Health Care Originals

Personalized AI-powered care for 1.3B people living with chronic conditions

https://wefunder.com/hco

Total raised on Wefunder: 1223237

Total investors: 539

Quick facts

  • 7.5x revenue growth since September 2025; on track for $1M MRR and cash-flow positivity in 2027
  • $129M ARR pipeline for Respiratory Care; 36 insurers in 11 states cover Neuro Care
  • $12M raised from venture funds including Safar Partners, Chloe Capital, Kingscrowd Capital, D3VC.ai
  • 67% of users report zero asthma or COPD attacks within 6 months
  • 26 patents issued & pending, including 2 AI patents
  • 2 AI agents deployed to predict crises from patient data & scale patient outreach
  • Featured in Forbes, USA Today, Masters of Scale, AAFA, & Kingscrowd; PurposeBuilt100 honoree
  • Unlocking a $900B+ opportunity across chronic health conditions by preventing emergency care

Investor memo sources

Team profiles

Featured investor profiles

Health Care Originals

Personalized AI-powered care for 1.3B people living with chronic conditions

Funded badge
Funded

Highlights

VC-Backed

Raised $250K or more from a venture firm

VC-Backed

Investment Memo

An investor has written an Investment Memo

Investment Memo
1
7.5x revenue growth since September 2025; on track for $1M MRR and cash-flow positivity in 2027
2
$129M ARR pipeline for Respiratory Care; 36 insurers in 11 states cover Neuro Care
3
$12M raised from venture funds including Safar Partners, Chloe Capital, Kingscrowd Capital, D3VC.ai
4
67% of users report zero asthma or COPD attacks within 6 months

Related company links

Featured Investors


Team


Memo

Health Care Originals is transforming at-home healthcare with AI-powered wearables and virtual therapy. We’re helping the 1.3 billion people living with chronic health conditions breathe, move, speak, and live easier.

Our technology detects and decodes body signals, enabling our care team to proactively offer care before visible problems or progress. We currently run two programs: HCO Respiratory and HCO Neuro.

In HCO Respiratory, our wearable (ADAMM) listens for signals a person cannot feel and turns what it detects into care that arrives before a crisis or ambulance siren. In HCO Neuro, our Imago Assist glove restores independence for stroke survivors one motion at a time, helping people move their hand even when traditional therapy says there is no further progress.

Aidah is our single AI intelligence layer that powers both programs, compounding learnings for each to personalize their individual care.

Backed by $12M from leading venture funds, including Safar Partners, Chloe Capital, and Kingscrowd Capital, we are the Physical AI platform for chronic conditions. Physical AI – the convergence of artificial intelligence with hardware and smart devices – is rapidly gaining dominance as the only real moat in AI, and HCO is at the forefront with patented hardware, proprietary data, and validated outcomes compounding daily.

And it's working: our success is reflected in clinical outcomes, revenue, and pipeline.

Our moat is compounding: 2 purpose-built AI agents deployed, millions of health signals processed, 26 patents issued and pending, 450,000 covered lives under signed agreements, and a proven Physical AI platform inside a $900B chronic condition care market.

More than a billion people with chronic conditions are left in the dark. Every day, HCO shines a light on what their bodies have been trying to tell them.

Follow us to be the first to know about our next round.

Overview